Global Radiopharmaceuticals in Nuclear Medicine Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

Report ID: GIR2201140562 | Category: Pharma & Healthcare | Pages: 124 | Format: PDF | Published Date: March 01,2022

Request Sample Enquiry before buying Ask For Discount

Single User-$3480.00 Multi User-$5220.00

Report Description
View Table of Contents

Report Summary

The Radiopharmaceuticals in Nuclear Medicine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Radiopharmaceuticals in Nuclear Medicine market size is estimated to be worth US$ 4943.7 million in 2021 and is forecast to a readjusted size of USD 6857.2 million by 2028 with a CAGR of 4.8% during review period. Diagnostic Application accounting for % of the Radiopharmaceuticals in Nuclear Medicine global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Diagnostic Radiopharmaceuticals segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Radiopharmaceuticals in Nuclear Medicine include Bracco Imaging S.P.A., Cambridge Isotope Laboratories, Inc., Cardinal Health, Inc., Covidien, Plc, and Eczacibasi-Monrol, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Radiopharmaceuticals in Nuclear Medicine market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Diagnostic Radiopharmaceuticals
Therapy Radiopharmaceuticals
Enriched Stable Isotopes
Market segment by Application can be divided into
Diagnostic Application
Therapeutic Application
Research
Pharmaceutical
Other
The key market players for global Radiopharmaceuticals in Nuclear Medicine market are listed below:
Bracco Imaging S.P.A.
Cambridge Isotope Laboratories, Inc.
Cardinal Health, Inc.
Covidien, Plc
Eczacibasi-Monrol
Fujifilm Holdings Corporation
GE Healthcare (Subsidiary Of General Electric Company)
IBA Group
Isotec, Inc. (Sigma-Aldrich)
Lantheus Medical Imaging, Inc.
Nordion, Inc.
Ntp Radioisotopes (Pty), Ltd.
Siemens Healthcare (Subsidiary Of Siemens AG)
Taiyo Nippon Sanso Corporation
Urenco Limited
Rotem Industries, Ltd., Inc.
Australian Nuclear Association And Technology Organization (ANSTO)
Board of Radiation And Isotope Technology (BRIT)
Institute of Atomic Energy Polatom Radioisotope Centre
Institute of Isotopes Co., Ltd.
Institute Of Radioelement (IRE)
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Radiopharmaceuticals in Nuclear Medicine product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Radiopharmaceuticals in Nuclear Medicine, with price, sales, revenue and global market share of Radiopharmaceuticals in Nuclear Medicine from 2019 to 2022.
Chapter 3, the Radiopharmaceuticals in Nuclear Medicine competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Radiopharmaceuticals in Nuclear Medicine breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Radiopharmaceuticals in Nuclear Medicine market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Radiopharmaceuticals in Nuclear Medicine.
Chapter 13, 14, and 15, to describe Radiopharmaceuticals in Nuclear Medicine sales channel, distributors, customers, research findings and conclusion, appendix and data source.

1 Market Overview
    1.1 Radiopharmaceuticals in Nuclear Medicine Introduction
    1.2 Market Analysis by Type
        1.2.1 Overview: Global Radiopharmaceuticals in Nuclear Medicine Revenue by Type: 2017 Versus 2021 Versus 2028
        1.2.2 Diagnostic Radiopharmaceuticals
        1.2.3 Therapy Radiopharmaceuticals
        1.2.4 Enriched Stable Isotopes
    1.3 Market Analysis by Application
        1.3.1 Overview: Global Radiopharmaceuticals in Nuclear Medicine Revenue by Application: 2017 Versus 2021 Versus 2028
        1.3.2 Diagnostic Application
        1.3.3 Therapeutic Application
        1.3.4 Research
        1.3.5 Pharmaceutical
        1.3.6 Other
    1.4 Global Radiopharmaceuticals in Nuclear Medicine Market Size & Forecast
        1.4.1 Global Radiopharmaceuticals in Nuclear Medicine Sales in Value (2017 & 2021 & 2028)
        1.4.2 Global Radiopharmaceuticals in Nuclear Medicine Sales in Volume (2017-2028)
        1.4.3 Global Radiopharmaceuticals in Nuclear Medicine Price (2017-2028) 
    1.5 Global Radiopharmaceuticals in Nuclear Medicine Production Capacity Analysis
        1.5.1 Global Radiopharmaceuticals in Nuclear Medicine Total Production Capacity (2017-2028)
        1.5.2 Global Radiopharmaceuticals in Nuclear Medicine Production Capacity by Geographic Region
    1.6 Market Drivers, Restraints and Trends
        1.6.1 Radiopharmaceuticals in Nuclear Medicine Market Drivers
        1.6.2 Radiopharmaceuticals in Nuclear Medicine Market Restraints
        1.6.3 Radiopharmaceuticals in Nuclear Medicine Trends Analysis
2 Manufacturers Profiles
    2.1 Bracco Imaging S.P.A.
        2.1.1 Bracco Imaging S.P.A. Details
        2.1.2 Bracco Imaging S.P.A. Major Business
        2.1.3 Bracco Imaging S.P.A. Radiopharmaceuticals in Nuclear Medicine Product and Services
        2.1.4 Bracco Imaging S.P.A. Radiopharmaceuticals in Nuclear Medicine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.2 Cambridge Isotope Laboratories, Inc.
        2.2.1 Cambridge Isotope Laboratories, Inc. Details
        2.2.2 Cambridge Isotope Laboratories, Inc. Major Business
        2.2.3 Cambridge Isotope Laboratories, Inc. Radiopharmaceuticals in Nuclear Medicine Product and Services
        2.2.4 Cambridge Isotope Laboratories, Inc. Radiopharmaceuticals in Nuclear Medicine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.3 Cardinal Health, Inc.
        2.3.1 Cardinal Health, Inc. Details
        2.3.2 Cardinal Health, Inc. Major Business
        2.3.3 Cardinal Health, Inc. Radiopharmaceuticals in Nuclear Medicine Product and Services
        2.3.4 Cardinal Health, Inc. Radiopharmaceuticals in Nuclear Medicine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.4 Covidien, Plc
        2.4.1 Covidien, Plc Details
        2.4.2 Covidien, Plc Major Business
        2.4.3 Covidien, Plc Radiopharmaceuticals in Nuclear Medicine Product and Services
        2.4.4 Covidien, Plc Radiopharmaceuticals in Nuclear Medicine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.5 Eczacibasi-Monrol
        2.5.1 Eczacibasi-Monrol Details
        2.5.2 Eczacibasi-Monrol Major Business
        2.5.3 Eczacibasi-Monrol Radiopharmaceuticals in Nuclear Medicine Product and Services
        2.5.4 Eczacibasi-Monrol Radiopharmaceuticals in Nuclear Medicine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.6 Fujifilm Holdings Corporation
        2.6.1 Fujifilm Holdings Corporation Details
        2.6.2 Fujifilm Holdings Corporation Major Business
        2.6.3 Fujifilm Holdings Corporation Radiopharmaceuticals in Nuclear Medicine Product and Services
        2.6.4 Fujifilm Holdings Corporation Radiopharmaceuticals in Nuclear Medicine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.7 GE Healthcare (Subsidiary Of General Electric Company)
        2.7.1 GE Healthcare (Subsidiary Of General Electric Company) Details
        2.7.2 GE Healthcare (Subsidiary Of General Electric Company) Major Business
        2.7.3 GE Healthcare (Subsidiary Of General Electric Company) Radiopharmaceuticals in Nuclear Medicine Product and Services
        2.7.4 GE Healthcare (Subsidiary Of General Electric Company) Radiopharmaceuticals in Nuclear Medicine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.8 IBA Group
        2.8.1 IBA Group Details
        2.8.2 IBA Group Major Business
        2.8.3 IBA Group Radiopharmaceuticals in Nuclear Medicine Product and Services
        2.8.4 IBA Group Radiopharmaceuticals in Nuclear Medicine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.9 Isotec, Inc. (Sigma-Aldrich)
        2.9.1 Isotec, Inc. (Sigma-Aldrich) Details
        2.9.2 Isotec, Inc. (Sigma-Aldrich) Major Business
        2.9.3 Isotec, Inc. (Sigma-Aldrich) Radiopharmaceuticals in Nuclear Medicine Product and Services
        2.9.4 Isotec, Inc. (Sigma-Aldrich) Radiopharmaceuticals in Nuclear Medicine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.10 Lantheus Medical Imaging, Inc.
        2.10.1 Lantheus Medical Imaging, Inc. Details
        2.10.2 Lantheus Medical Imaging, Inc. Major Business
        2.10.3 Lantheus Medical Imaging, Inc. Radiopharmaceuticals in Nuclear Medicine Product and Services
        2.10.4 Lantheus Medical Imaging, Inc. Radiopharmaceuticals in Nuclear Medicine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.11 Nordion, Inc.
        2.11.1 Nordion, Inc. Details
        2.11.2 Nordion, Inc. Major Business
        2.11.3 Nordion, Inc. Radiopharmaceuticals in Nuclear Medicine Product and Services
        2.11.4 Nordion, Inc. Radiopharmaceuticals in Nuclear Medicine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.12 Ntp Radioisotopes (Pty), Ltd.
        2.12.1 Ntp Radioisotopes (Pty), Ltd. Details
        2.12.2 Ntp Radioisotopes (Pty), Ltd. Major Business
        2.12.3 Ntp Radioisotopes (Pty), Ltd. Radiopharmaceuticals in Nuclear Medicine Product and Services
        2.12.4 Ntp Radioisotopes (Pty), Ltd. Radiopharmaceuticals in Nuclear Medicine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.13 Siemens Healthcare (Subsidiary Of Siemens AG)
        2.13.1 Siemens Healthcare (Subsidiary Of Siemens AG) Details
        2.13.2 Siemens Healthcare (Subsidiary Of Siemens AG) Major Business
        2.13.3 Siemens Healthcare (Subsidiary Of Siemens AG) Radiopharmaceuticals in Nuclear Medicine Product and Services
        2.13.4 Siemens Healthcare (Subsidiary Of Siemens AG) Radiopharmaceuticals in Nuclear Medicine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.14 Taiyo Nippon Sanso Corporation
        2.14.1 Taiyo Nippon Sanso Corporation Details
        2.14.2 Taiyo Nippon Sanso Corporation Major Business
        2.14.3 Taiyo Nippon Sanso Corporation Radiopharmaceuticals in Nuclear Medicine Product and Services
        2.14.4 Taiyo Nippon Sanso Corporation Radiopharmaceuticals in Nuclear Medicine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.15 Urenco Limited
        2.15.1 Urenco Limited Details
        2.15.2 Urenco Limited Major Business
        2.15.3 Urenco Limited Radiopharmaceuticals in Nuclear Medicine Product and Services
        2.15.4 Urenco Limited Radiopharmaceuticals in Nuclear Medicine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.16 Rotem Industries, Ltd., Inc.
        2.16.1 Rotem Industries, Ltd., Inc. Details
        2.16.2 Rotem Industries, Ltd., Inc. Major Business
        2.16.3 Rotem Industries, Ltd., Inc. Radiopharmaceuticals in Nuclear Medicine Product and Services
        2.16.4 Rotem Industries, Ltd., Inc. Radiopharmaceuticals in Nuclear Medicine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.17 Australian Nuclear Association And Technology Organization (ANSTO)
        2.17.1 Australian Nuclear Association And Technology Organization (ANSTO) Details
        2.17.2 Australian Nuclear Association And Technology Organization (ANSTO) Major Business
        2.17.3 Australian Nuclear Association And Technology Organization (ANSTO) Radiopharmaceuticals in Nuclear Medicine Product and Services
        2.17.4 Australian Nuclear Association And Technology Organization (ANSTO) Radiopharmaceuticals in Nuclear Medicine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.18 Board of Radiation And Isotope Technology (BRIT)
        2.18.1 Board of Radiation And Isotope Technology (BRIT) Details
        2.18.2 Board of Radiation And Isotope Technology (BRIT) Major Business
        2.18.3 Board of Radiation And Isotope Technology (BRIT) Radiopharmaceuticals in Nuclear Medicine Product and Services
        2.18.4 Board of Radiation And Isotope Technology (BRIT) Radiopharmaceuticals in Nuclear Medicine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.19 Institute of Atomic Energy Polatom Radioisotope Centre
        2.19.1 Institute of Atomic Energy Polatom Radioisotope Centre Details
        2.19.2 Institute of Atomic Energy Polatom Radioisotope Centre Major Business
        2.19.3 Institute of Atomic Energy Polatom Radioisotope Centre Radiopharmaceuticals in Nuclear Medicine Product and Services
        2.19.4 Institute of Atomic Energy Polatom Radioisotope Centre Radiopharmaceuticals in Nuclear Medicine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.20 Institute of Isotopes Co., Ltd.
        2.20.1 Institute of Isotopes Co., Ltd. Details
        2.20.2 Institute of Isotopes Co., Ltd. Major Business
        2.20.3 Institute of Isotopes Co., Ltd. Radiopharmaceuticals in Nuclear Medicine Product and Services
        2.20.4 Institute of Isotopes Co., Ltd. Radiopharmaceuticals in Nuclear Medicine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.21 Institute Of Radioelement (IRE)
        2.21.1 Institute Of Radioelement (IRE) Details
        2.21.2 Institute Of Radioelement (IRE) Major Business
        2.21.3 Institute Of Radioelement (IRE) Radiopharmaceuticals in Nuclear Medicine Product and Services
        2.21.4 Institute Of Radioelement (IRE) Radiopharmaceuticals in Nuclear Medicine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Radiopharmaceuticals in Nuclear Medicine Breakdown Data by Manufacturer
    3.1 Global Radiopharmaceuticals in Nuclear Medicine Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
    3.2 Global Radiopharmaceuticals in Nuclear Medicine Revenue by Manufacturer (2019, 2020, 2021, and 2022)
    3.3 Key Manufacturer Market Position in Radiopharmaceuticals in Nuclear Medicine
    3.4 Market Concentration Rate
        3.4.1 Top 3 Radiopharmaceuticals in Nuclear Medicine Manufacturer Market Share in 2021
        3.4.2 Top 6 Radiopharmaceuticals in Nuclear Medicine Manufacturer Market Share in 2021
    3.5 Global Radiopharmaceuticals in Nuclear Medicine Production Capacity by Company: 2021 VS 2022
    3.6 Manufacturer by Geography: Head Office and Radiopharmaceuticals in Nuclear Medicine Production Site
    3.7 New Entrant and Capacity Expansion Plans
    3.8 Mergers & Acquisitions
4 Market Analysis by Region
    4.1 Global Radiopharmaceuticals in Nuclear Medicine Market Size by Region
        4.1.1 Global Radiopharmaceuticals in Nuclear Medicine Sales in Volume by Region (2017-2028)
        4.1.2 Global Radiopharmaceuticals in Nuclear Medicine Revenue by Region (2017-2028)
    4.2 North America Radiopharmaceuticals in Nuclear Medicine Revenue (2017-2028)
    4.3 Europe Radiopharmaceuticals in Nuclear Medicine Revenue (2017-2028)
    4.4 Asia-Pacific Radiopharmaceuticals in Nuclear Medicine Revenue (2017-2028)
    4.5 South America Radiopharmaceuticals in Nuclear Medicine Revenue (2017-2028)
    4.6 Middle East and Africa Radiopharmaceuticals in Nuclear Medicine Revenue (2017-2028)
5 Market Segment by Type
    5.1 Global Radiopharmaceuticals in Nuclear Medicine Sales in Volume by Type (2017-2028)
    5.2 Global Radiopharmaceuticals in Nuclear Medicine Revenue by Type (2017-2028)
    5.3 Global Radiopharmaceuticals in Nuclear Medicine Price by Type (2017-2028)
6 Market Segment by Application
    6.1 Global Radiopharmaceuticals in Nuclear Medicine Sales in Volume by Application (2017-2028)
    6.2 Global Radiopharmaceuticals in Nuclear Medicine Revenue by Application (2017-2028)
    6.3 Global Radiopharmaceuticals in Nuclear Medicine Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
    7.1 North America Radiopharmaceuticals in Nuclear Medicine Sales by Type (2017-2028)
    7.2 North America Radiopharmaceuticals in Nuclear Medicine Sales by Application (2017-2028)
    7.3 North America Radiopharmaceuticals in Nuclear Medicine Market Size by Country
        7.3.1 North America Radiopharmaceuticals in Nuclear Medicine Sales in Volume by Country (2017-2028)
        7.3.2 North America Radiopharmaceuticals in Nuclear Medicine Revenue by Country (2017-2028)
        7.3.3 United States Market Size and Forecast (2017-2028)
        7.3.4 Canada Market Size and Forecast (2017-2028)
        7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
    8.1 Europe Radiopharmaceuticals in Nuclear Medicine Sales by Type (2017-2028)
    8.2 Europe Radiopharmaceuticals in Nuclear Medicine Sales by Application (2017-2028)
    8.3 Europe Radiopharmaceuticals in Nuclear Medicine Market Size by Country
        8.3.1 Europe Radiopharmaceuticals in Nuclear Medicine Sales in Volume by Country (2017-2028)
        8.3.2 Europe Radiopharmaceuticals in Nuclear Medicine Revenue by Country (2017-2028)
        8.3.3 Germany Market Size and Forecast (2017-2028)
        8.3.4 France Market Size and Forecast (2017-2028)
        8.3.5 United Kingdom Market Size and Forecast (2017-2028)
        8.3.6 Russia Market Size and Forecast (2017-2028)
        8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
    9.1 Asia-Pacific Radiopharmaceuticals in Nuclear Medicine Sales by Type (2017-2028)
    9.2 Asia-Pacific Radiopharmaceuticals in Nuclear Medicine Sales by Application (2017-2028)
    9.3 Asia-Pacific Radiopharmaceuticals in Nuclear Medicine Market Size by Region
        9.3.1 Asia-Pacific Radiopharmaceuticals in Nuclear Medicine Sales in Volume by Region (2017-2028)
        9.3.2 Asia-Pacific Radiopharmaceuticals in Nuclear Medicine Revenue by Region (2017-2028)
        9.3.3 China Market Size and Forecast (2017-2028)
        9.3.4 Japan Market Size and Forecast (2017-2028)
        9.3.5 Korea Market Size and Forecast (2017-2028)
        9.3.6 India Market Size and Forecast (2017-2028)
        9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
        9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
    10.1 South America Radiopharmaceuticals in Nuclear Medicine Sales by Type (2017-2028)
    10.2 South America Radiopharmaceuticals in Nuclear Medicine Sales by Application (2017-2028)
    10.3 South America Radiopharmaceuticals in Nuclear Medicine Market Size by Country
        10.3.1 South America Radiopharmaceuticals in Nuclear Medicine Sales in Volume by Country (2017-2028)
        10.3.2 South America Radiopharmaceuticals in Nuclear Medicine Revenue by Country (2017-2028)
        10.3.3 Brazil Market Size and Forecast (2017-2028)
        10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
    11.1 Middle East & Africa Radiopharmaceuticals in Nuclear Medicine Sales by Type (2017-2028)
    11.2 Middle East & Africa Radiopharmaceuticals in Nuclear Medicine Sales by Application (2017-2028)
    11.3 Middle East & Africa Radiopharmaceuticals in Nuclear Medicine Market Size by Country
        11.3.1 Middle East & Africa Radiopharmaceuticals in Nuclear Medicine Sales in Volume by Country (2017-2028)
        11.3.2 Middle East & Africa Radiopharmaceuticals in Nuclear Medicine Revenue by Country (2017-2028)
        11.3.3 Turkey Market Size and Forecast (2017-2028)
        11.3.4 Egypt Market Size and Forecast (2017-2028)
        11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
        11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
    12.1 Raw Material of Radiopharmaceuticals in Nuclear Medicine and Key Manufacturers
    12.2 Manufacturing Costs Percentage of Radiopharmaceuticals in Nuclear Medicine
    12.3 Radiopharmaceuticals in Nuclear Medicine Production Process
    12.4 Radiopharmaceuticals in Nuclear Medicine Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
    13.1 Sales Channel
        13.1.1 Direct Marketing
        13.1.2 Indirect Marketing
    13.2 Radiopharmaceuticals in Nuclear Medicine Typical Distributors
    13.3 Radiopharmaceuticals in Nuclear Medicine Typical Customers
14 Research Findings and Conclusion
15 Appendix
    15.1 Methodology
    15.2 Research Process and Data Source
    15.3 Disclaimer

FAQ's

What does the report cover (Scope)?

It contains all the geographic trends, and market analysis for global market

ENTER REPORT NAME TO SEARCH

Global Radiopharmaceuticals in Nuclear Medicine Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

Report Summary

Table of Contents

FAQ's

What does the report cover (Scope)?